Salicylic acid

Description

The product is identified by SPL code 34089-3 and is classified as a Hydrating Anti-Blemish Body Wash. This formulation is designed to cleanse and hydrate the skin, incorporating active ingredients that facilitate these functions. The product contains a blend of surfactants and moisturizers, which work synergistically to enhance skin texture and effectiveness. Inactive ingredients include water, glycerin, and additional components that contribute to the overall formulation.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears acne pimples and facilitates the healing of the skin. Additionally, it helps prevent the formation of new acne pimples.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The product is to be used daily during showering or bathing. Healthcare professionals should instruct patients to massage the product over wet skin using a washcloth or body puff, with particular attention to areas that are prone to breakouts. It is essential to rinse the skin thoroughly after application. If necessary, patients may follow with a non-comedogenic moisturizer to maintain skin hydration and prevent dryness.

Contraindications

Use of this product is contraindicated in the following situations:

Contact with the eyes should be avoided; in the event of contact, the eyes must be flushed thoroughly with water to prevent irritation. Concurrent use with other topical acne medications is not recommended, as this may increase the likelihood of skin irritation and dryness. If irritation occurs, it is advised to limit use to one topical acne medication at a time.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid contact with the eyes. In the event of accidental contact, it is imperative to flush the eyes thoroughly with water to mitigate potential irritation.

When utilizing this product, the likelihood of skin irritation and dryness may increase if another topical acne medication is used concurrently. Therefore, it is recommended that patients use only one topical acne medication at a time to minimize the risk of adverse skin reactions.

Pregnant or breastfeeding individuals should consult a healthcare professional prior to use to ensure safety for both the mother and child.

This product must be kept out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised to ensure appropriate management.

Side Effects

For external use only. Patients are advised to avoid contact with the eyes; in the event of contact, it is recommended to flush the eyes thoroughly with water.

Skin irritation and dryness have been reported as common adverse reactions, particularly when this product is used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that patients use only one topical acne medication at a time.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Oxy Hydrating Anti-Blemish Body Wash. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

If pregnant or breast-feeding, it is advised to consult a health professional prior to use. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the importance of prompt action in such situations.

Patients should be informed to avoid contact with their eyes. In the event of accidental eye contact, they should flush the eyes thoroughly with water to minimize potential irritation.

Additionally, healthcare providers should counsel patients about the risk of skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is recommended that patients use only one topical acne medication at a time to reduce the likelihood of irritation.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity and effectiveness.

To ensure safety, the product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised. Special handling precautions should be observed to prevent misuse or accidental exposure.

Additional Clinical Information

The product is administered topically and is intended for daily use during showering or bathing. Clinicians should advise patients to avoid contact with the eyes; in the event of contact, thorough flushing with water is recommended. Patients may experience increased skin irritation and dryness if using another topical acne medication concurrently; therefore, it is advised to use only one topical acne medication at a time to minimize irritation.

Additionally, patients who are pregnant or breastfeeding should consult a healthcare professional prior to use to ensure safety. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Oxy Hydrating Anti-Blemish Body Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)